• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人肺炎病因的演变认识,特别关注肺炎球菌的作用。

Evolving Understanding of the Causes of Pneumonia in Adults, With Special Attention to the Role of Pneumococcus.

机构信息

Departments of Medicine and Molecular Virology and Microbiology, Baylor College of Medicine.

Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.

出版信息

Clin Infect Dis. 2017 Oct 30;65(10):1736-1744. doi: 10.1093/cid/cix549.

DOI:10.1093/cid/cix549
PMID:29028977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7108120/
Abstract

Before 1945, Streptococcus pneumoniae caused more than 90% of cases of pneumonia in adults. After 1950, the proportion of pneumonia caused by pneumococcus began to decline. Pneumococcus has continued to decline; at present, this organism is identified in fewer than fewer10%-15% of cases. This proportion is higher in Europe, a finding likely related to differences in vaccination practices and smoking. Gram-negative bacilli, Staphylococcus aureus, Chlamydia, Mycoplasma, and Legionella are each identified in 2%-5% of patients with pneumonia who require hospitalization. Viruses are found in 25% of patients, up to one-third of these have bacterial coinfection. Recent studies fail to identify a causative organism in more than 50% of cases, which remains the most important challenge to understanding lower respiratory infection. Our findings have important implications for antibiotic stewardship and should be considered as new policies for empiric pneumonia management are developed.

摘要

在 1945 年以前,肺炎链球菌导致了超过 90%的成人肺炎病例。自 1950 年以来,肺炎球菌引起的肺炎比例开始下降。肺炎球菌的比例一直在持续下降;目前,这种病原体在不到 10%-15%的病例中被识别出来。这种比例在欧洲更高,这一发现可能与接种疫苗的做法和吸烟的差异有关。需要住院治疗的肺炎患者中,有 2%-5%的患者可培养出革兰氏阴性杆菌、金黄色葡萄球菌、衣原体、支原体和军团菌。病毒在 25%的患者中被发现,其中多达三分之一的患者存在细菌合并感染。最近的研究发现,超过 50%的病例未能确定病原体,这仍然是理解下呼吸道感染的最大挑战。我们的研究结果对抗生素管理具有重要意义,应在制定新的经验性肺炎管理政策时予以考虑。

相似文献

1
Evolving Understanding of the Causes of Pneumonia in Adults, With Special Attention to the Role of Pneumococcus.成人肺炎病因的演变认识,特别关注肺炎球菌的作用。
Clin Infect Dis. 2017 Oct 30;65(10):1736-1744. doi: 10.1093/cid/cix549.
2
Community-acquired pneumonia and positive urinary antigen tests: Factors associated with targeted antibiotic therapy.社区获得性肺炎与尿抗原检测阳性:与靶向抗生素治疗相关的因素
Med Mal Infect. 2016 Oct;46(7):365-371. doi: 10.1016/j.medmal.2016.05.009. Epub 2016 Jul 1.
3
[Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia].[尿肺炎球菌或军团菌抗原检测试验及社区获得性肺炎的窄谱抗生素治疗]
Med Mal Infect. 2010 Jun;40(6):347-51. doi: 10.1016/j.medmal.2010.01.005. Epub 2010 Feb 20.
4
Community-acquired pneumonia in adults.成人社区获得性肺炎
West J Med. 1994 Oct;161(4):383-9.
5
Epidemiology, aetiology and management of childhood acute community-acquired pneumonia in developing countries--a review.发展中国家儿童急性社区获得性肺炎的流行病学、病因学及管理——综述
Afr J Med Med Sci. 2011 Dec;40(4):293-308.
6
Pneumococcal community-acquired pneumonia in 148 hospitalized adult patients.148例住院成年患者的肺炎球菌社区获得性肺炎
Eur J Clin Microbiol Infect Dis. 1997 Dec;16(12):863-70. doi: 10.1007/BF01700551.
7
[A multicentre study on the pathogenic agents in 665 adult patients with community-acquired pneumonia in cities of China].[中国城市665例成人社区获得性肺炎病原菌的多中心研究]
Zhonghua Jie He He Hu Xi Za Zhi. 2006 Jan;29(1):3-8.
8
The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy.重症社区获得性肺炎的病因及其对初始经验性抗菌化疗的影响。
Respir Med. 1995 Mar;89(3):187-92. doi: 10.1016/0954-6111(95)90246-5.
9
Sustained Impact of an Antibiotic Stewardship Intervention for Community-Acquired Pneumonia.抗生素管理干预对社区获得性肺炎的持续影响。
Infect Control Hosp Epidemiol. 2016 Oct;37(10):1243-6. doi: 10.1017/ice.2016.165. Epub 2016 Aug 8.
10
Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.呼吸道监测项目研究中社区获得性呼吸道感染的病原体出现频率及抗菌药物敏感性:来自医疗办公室实践环境的微生物学情况
Am J Med. 2001 Dec 17;111 Suppl 9A:4S-12S; discussion 36S-38S. doi: 10.1016/s0002-9343(01)01025-7.

引用本文的文献

1
Risk factors for pneumonitis after the combination treatment of immune checkpoint inhibitors and thoracic radiotherapy.免疫检查点抑制剂与胸部放疗联合治疗后肺炎的危险因素。
BMC Pulm Med. 2025 Aug 25;25(1):404. doi: 10.1186/s12890-025-03871-y.
2
A systematic algorithm using 16S ribosomal RNA for accurate diagnosis of pneumonia pathogens.一种使用16S核糖体RNA准确诊断肺炎病原体的系统算法。
Sci Rep. 2025 Aug 10;15(1):29253. doi: 10.1038/s41598-025-14841-z.
3
Application value of metagenomic next-generation sequencing based on protective bronchoalveolar lavage in nonresponding pneumonia.基于保护性支气管肺泡灌洗的宏基因组下一代测序在无反应性肺炎中的应用价值
Microbiol Spectr. 2025 Jul;13(7):e0313824. doi: 10.1128/spectrum.03138-24. Epub 2025 May 29.
4
Exploring the respiratory viral landscape beyond influenza and SARS-CoV-2: a 2020-2023 study in Fujian, China.探索流感和新冠病毒之外的呼吸道病毒格局:2020 - 2023年中国福建的一项研究
Front Public Health. 2025 May 14;13:1558716. doi: 10.3389/fpubh.2025.1558716. eCollection 2025.
5
Performance of BIOFIRE FILMARRAY pneumonia panel in suspected pneumonia: insights from a real-world study.BIOFIRE FILMARRAY肺炎检测板在疑似肺炎中的表现:一项真实世界研究的见解
Microbiol Spectr. 2025 Jul;13(7):e0057125. doi: 10.1128/spectrum.00571-25. Epub 2025 May 22.
6
A Phase 3 Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Vaccine, Compared with PPSV23, in Adults ≥50 Years of Age (STRIDE-10).一项3期随机试验,在≥50岁成人中比较成人专用肺炎球菌疫苗V116与23价肺炎球菌多糖疫苗(PPSV23)的安全性、耐受性和免疫原性(STRIDE-10)。
Vaccines (Basel). 2025 Mar 22;13(4):341. doi: 10.3390/vaccines13040341.
7
Alterations in the prevalence and serotypes of Streptococcus pneumoniae in elderly patients with community-acquired pneumonia: a meta-analysis and systematic review.老年社区获得性肺炎患者肺炎链球菌的患病率及血清型变化:一项荟萃分析与系统评价
Pneumonia (Nathan). 2025 Feb 25;17(1):5. doi: 10.1186/s41479-025-00156-0.
8
Optimizing Neutrophil Recruitment to Tackle Bacterial Infections.优化中性粒细胞募集以应对细菌感染。
Am J Respir Cell Mol Biol. 2025 Jul;73(1):3-5. doi: 10.1165/rcmb.2024-0575ED.
9
Description and characterization of pneumococcal community acquired pneumonia (CAP) among radiologically confirmed CAP in outpatients.门诊放射学确诊的社区获得性肺炎(CAP)患者中肺炎球菌性CAP的描述与特征分析
NPJ Prim Care Respir Med. 2025 Jan 4;35(1):1. doi: 10.1038/s41533-024-00405-7.
10
Pleural space infection microbiology as assessed using a clinical sequencing-based assay: group, and other oral normal microbiota are the most common bacteria identified in community-acquired pleural space infections.使用基于临床测序的检测方法评估的胸膜腔感染微生物学:在社区获得性胸膜腔感染中,厌氧菌和其他口腔正常微生物群是最常见的细菌。
J Clin Microbiol. 2024 Dec 11;62(12):e0069424. doi: 10.1128/jcm.00694-24. Epub 2024 Nov 25.

本文引用的文献

1
SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia.SOLITAIRE-IV:一项比较静脉-口服索利霉素与静脉-口服莫西沙星治疗社区获得性细菌性肺炎的疗效和安全性的随机、双盲、多中心研究。
Clin Infect Dis. 2016 Oct 15;63(8):1007-1016. doi: 10.1093/cid/ciw490. Epub 2016 Jul 22.
2
The Relevance of a Novel Quantitative Assay to Detect up to 40 Major Streptococcus pneumoniae Serotypes Directly in Clinical Nasopharyngeal and Blood Specimens.一种新型定量检测方法在临床鼻咽和血液标本中直接检测多达40种主要肺炎链球菌血清型的相关性。
PLoS One. 2016 Mar 17;11(3):e0151428. doi: 10.1371/journal.pone.0151428. eCollection 2016.
3
Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL).口服索利霉素与口服莫西沙星治疗社区获得性细菌性肺炎的疗效和安全性:一项全球性、双盲、多中心、随机、阳性对照、非劣效性试验(SOLITAIRE-ORAL)。
Lancet Infect Dis. 2016 Apr;16(4):421-30. doi: 10.1016/S1473-3099(16)00017-7. Epub 2016 Feb 5.
4
Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia.社区获得性肺炎中呼吸道病原体的综合分子检测
Clin Infect Dis. 2016 Apr 1;62(7):817-823. doi: 10.1093/cid/civ1214. Epub 2016 Jan 7.
5
Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).PCV13 与 PPSV23 疫苗接种间隔:免疫实践咨询委员会(ACIP)的建议。
MMWR Morb Mortal Wkly Rep. 2015 Sep 4;64(34):944-7. doi: 10.15585/mmwr.mm6434a4.
6
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults.美国成年人中需要住院治疗的社区获得性肺炎
N Engl J Med. 2015 Jul 30;373(5):415-27. doi: 10.1056/NEJMoa1500245. Epub 2015 Jul 14.
7
Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.多糖结合疫苗预防成人肺炎球菌性肺炎。
N Engl J Med. 2015 Mar 19;372(12):1114-25. doi: 10.1056/NEJMoa1408544.
8
Aetiology and risk factors of community-acquired pneumonia in hospitalized patients in Norway.挪威住院患者社区获得性肺炎的病因及危险因素
Clin Respir J. 2016 Nov;10(6):756-764. doi: 10.1111/crj.12283. Epub 2015 Apr 6.
9
Community-acquired pneumonia.社区获得性肺炎
N Engl J Med. 2014 Oct 23;371(17):1619-28. doi: 10.1056/NEJMra1312885.
10
Predicting pneumococcal community-acquired pneumonia in the emergency department: evaluation of clinical parameters.预测急诊科的肺炎球菌性社区获得性肺炎:临床参数评估。
Clin Microbiol Infect. 2014 Dec;20(12):1316-22. doi: 10.1111/1469-0691.12740. Epub 2014 Dec 12.